MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Xenomics, Inc. (XNOM.PK), a developer of non-invasive next-generation molecular diagnostics, announced today that Dr. Samuil Umansky, Chief Scientific Officer, presented today at the 52nd All India Congress of Obstetrics & Gynecology (AICOG) in Jaipur, India. Dr. Umansky provided an overview of the current state of Human Papilloma Virus (HPV) detection and cervical cancer diagnostics and discussed a urine-based HPV screening test developed by Xenomics.
